This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2016 Oct 15;388(10054):1853-1854.

doi: 10.1016/S0140-6736(16)31394-0. Epub 2016 Aug 23.

Gemcitabine: a game changer in nasopharyngeal carcinoma

Melvin L K Chua¹, Anthony T C Chan²

Affiliations

Affiliations

¹ Division of Radiation Oncology, National Cancer Centre Singapore 169610, Singapore, Singapore; Duke-NUS Graduate Medical School, Singapore, Singapore. Electronic address: melvin.chua.l.k@nccs.com.sg.
² State Key Laboratory of Oncology in South China, Sir Y K Pao Centre for Cancer, Department of Clinical Oncology, Hong Kong Cancer Institute, The Chinese University of Hong Kong, Hong Kong, China.

PMID: 27567280
DOI: 10.1016/S0140-6736(16)31394-0

Comment

Gemcitabine: a game changer in nasopharyngeal carcinoma

Melvin L K Chua et al. Lancet. 2016.

. 2016 Oct 15;388(10054):1853-1854.

doi: 10.1016/S0140-6736(16)31394-0. Epub 2016 Aug 23.

Authors

Melvin L K Chua¹, Anthony T C Chan²

Affiliations

¹ Division of Radiation Oncology, National Cancer Centre Singapore 169610, Singapore, Singapore; Duke-NUS Graduate Medical School, Singapore, Singapore. Electronic address: melvin.chua.l.k@nccs.com.sg.
² State Key Laboratory of Oncology in South China, Sir Y K Pao Centre for Cancer, Department of Clinical Oncology, Hong Kong Cancer Institute, The Chinese University of Hong Kong, Hong Kong, China.

PMID: 27567280
DOI: 10.1016/S0140-6736(16)31394-0

No abstract available

PubMed Disclaimer

Comment on

Gemcitabine plus cisplatin versus fluorouracil plus cisplatin in recurrent or metastatic nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase 3 trial.
Zhang L, Huang Y, Hong S, Yang Y, Yu G, Jia J, Peng P, Wu X, Lin Q, Xi X, Peng J, Xu M, Chen D, Lu X, Wang R, Cao X, Chen X, Lin Z, Xiong J, Lin Q, Xie C, Li Z, Pan J, Li J, Wu S, Lian Y, Yang Q, Zhao C. Zhang L, et al. Lancet. 2016 Oct 15;388(10054):1883-1892. doi: 10.1016/S0140-6736(16)31388-5. Epub 2016 Aug 23. Lancet. 2016. PMID: 27567279 Clinical Trial.

Similar articles

[Establishment and analysis of a database for genes and literature related to nasopharyngeal carcinoma].
Zeng ZY, Xiong W, Li XL. Zeng ZY, et al. Hunan Yi Ke Da Xue Xue Bao. 2003 Feb 28;28(1):1-4. Hunan Yi Ke Da Xue Xue Bao. 2003. PMID: 12934381 Chinese.
Interleukin-10 levels in Epstein-Barr virus-associated nasopharyngeal carcinoma.
Budiani DR, Hutahaean S, Haryana SM, Soesatyo MH, Sosroseno W. Budiani DR, et al. J Microbiol Immunol Infect. 2002 Dec;35(4):265-8. J Microbiol Immunol Infect. 2002. PMID: 12542255
[Dermatomyositis and nasopharyngeal carcinoma: 3 cases].
Boussen H, Mebazaa A, Gritli S, Khalfallah S, Touati S, El May A, Benna F, Ben Ayed F, Nouira R, Bouaouina N, Ladgham A. Boussen H, et al. Ann Dermatol Venereol. 2000 Apr;127(4):389-92. Ann Dermatol Venereol. 2000. PMID: 10844259 French.
[Expression of PML in carcinogenesis of laryngocarcinoma and nasopharyngeal carcinoma].
Chen W, Yao W, Chen S, Xiao B, Tao Z. Chen W, et al. Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2007 Feb;21(3):128-31. Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2007. PMID: 17441430 Chinese.
Nasopharyngeal carcinoma presenting as carotidynia in an 18-year-old patient.
Ellul D, Cutajar J, Borg Xuereb H, Said M. Ellul D, et al. J Laryngol Otol. 2008 Feb;122(2):207-9. doi: 10.1017/S0022215107007293. Epub 2007 Apr 10. J Laryngol Otol. 2008. PMID: 17419895 Review.

See all similar articles

Cited by

Altered properties of brain white matter structural networks in patients with nasopharyngeal carcinoma after radiotherapy.
Chen Q, Lv X, Zhang S, Lin J, Song J, Cao B, Weng Y, Li L, Huang R. Chen Q, et al. Brain Imaging Behav. 2020 Dec;14(6):2745-2761. doi: 10.1007/s11682-019-00224-2. Brain Imaging Behav. 2020. PMID: 31900892
Prognostic value of nutritional risk screening 2002 scale in nasopharyngeal carcinoma: A large-scale cohort study.
Peng H, Chen BB, Tang LL, Chen L, Li WF, Zhang Y, Mao YP, Sun Y, Liu LZ, Tian L, Guo Y, Ma J. Peng H, et al. Cancer Sci. 2018 Jun;109(6):1909-1919. doi: 10.1111/cas.13603. Epub 2018 May 18. Cancer Sci. 2018. PMID: 29624824 Free PMC article.
Construction of nomograms for nasopharyngeal carcinoma containing primary tumor size and SEER stage.
Yang G, Luo B, Yang Q, Chen M, Yang X, Sun J. Yang G, et al. Transl Cancer Res. 2020 Nov;9(11):6939-6954. doi: 10.21037/tcr-20-2080. Transl Cancer Res. 2020. PMID: 35117302 Free PMC article.
Clinical characteristics and prognostic value of pre-retreatment plasma epstein-barr virus DNA in locoregional recurrent nasopharyngeal carcinoma.
Liu MZ, Fang SG, Huang W, Wang HY, Tian YM, Huang RD, Sun Z, Zhao C, Lu TX, Huang Y, Han F. Liu MZ, et al. Cancer Med. 2019 Aug;8(10):4633-4643. doi: 10.1002/cam4.2339. Epub 2019 Jul 3. Cancer Med. 2019. PMID: 31268626 Free PMC article.
Hypoxia-Induced Matrix Metalloproteinase-13 Expression in Exosomes from Nasopharyngeal Carcinoma Enhances Metastases.
Shan Y, You B, Shi S, Shi W, Zhang Z, Zhang Q, Gu M, Chen J, Bao L, Liu D, You Y. Shan Y, et al. Cell Death Dis. 2018 Mar 7;9(3):382. doi: 10.1038/s41419-018-0425-0. Cell Death Dis. 2018. PMID: 29515112 Free PMC article.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions

Associated data

Actions
- Search in PubMed
- Search in ClinicalTrials.gov
Actions
- Search in PubMed
- Search in ClinicalTrials.gov

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Other Literature Sources
- scite Smart Citations
Medical
- ClinicalTrials.gov